B.S., The University of Texas at Austin, College of Pharmacy, Austin, Texas, 1985.
Pharm.D., The University of Texas at Austin, College of Pharmacy, and The University of Texas Health Science Center at San Antonio, San Antonio, Texas, 1992.
M.B.A., The George Washington University, Washington, D.C., 2012.

Postdoctoral training: South Texas Veteran’s Healthcare System, San Antonio, Texas (specialty residency in hematology/oncology), 1992-1993; The University of Texas M.D. Anderson Cancer Center, Houston, Texas (clinical pharmacology fellowship), 1993-1995.

Certified by the Board of Pharmacy Specialties as a Board Certified Oncology Pharmacist (BCOP).

The University of Texas M.D. Anderson Cancer Center, Houston, Texas, staff pharmacist, 1985-1986; evening shift supervisor, 1986-1987; St. David’s Community Hospital, Austin, Texas, staff pharmacist, 1987-1989; Brackenridge Hospital and Children’s Hospital of Austin at Brackenridge, Austin, Texas, staff pharmacist, 1989-1990; Texas Tech University Health Sciences Center at Amarillo School of Pharmacy, Department of Pharmacy Practice, Amarillo, Texas, Assistant Professor of Pharmacy Practice, 1995-1997; The University of Texas Medical Branch, Galveston, Texas, director, Pharmacy Residency Program, 1997-1999; clinical specialist – Hematology/Oncology, 1997-2000; The University of Texas at Austin, Austin, Texas, Clinical Assistant Professor, 1997-2011; South Texas Veterans Health Care System, Audie Murphy Hospital Division, San Antonio, Texas, clinical oncology pharmacist, 2000-2003; director, Oncology Pharmacy PGY2 Residency Program, 2000-2003; Amgen, Inc., San Antonio, Texas, oncology regional medical liaison, 2003-2007; The University of Texas Health Science Center, San Antonio, Texas, director, Investigational Drug Section, Cancer Therapy and Research Center, and director, Oncology Pharmacy PGY2 Residency Program, 2007-2011; New Haven Hospital, New Haven, Conn., associate director, Oncology Pharmacy Services, Smilow Cancer Hospital at Yale New Haven, and director, Oncology Pharmacy PGY2 Residency Program, 2011-2014; The University of Texas Seton Shoal Creek Hospital, Austin, Texas, Director of Pharmacy, Dell Seton Medical Center, 2014-2017.

Joined Mayo Clinic, 2017; Assistant Professor of Pharmacy, Mayo Clinic College of Medicine and Science, 2017-2024; Associate Professor, 2024-present; director, PGY2 Oncology Pharmacy Residency, 2019-2020; director, Pharmacy Cancer Care, 2017-present.